Syndrome des jambes sans repos chez la personne âgée: une affection méconnue [Restless legs syndrome in the elderly: an unrecognized disorder].
Details
Download: RMS_idPAS_D_ISBN_pu2008-40s_sa03_art03.pdf (226.90 [Ko])
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_239D5E53DD1B
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Syndrome des jambes sans repos chez la personne âgée: une affection méconnue [Restless legs syndrome in the elderly: an unrecognized disorder].
Journal
Revue Médicale Suisse
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
2008
Peer-reviewed
Oui
Volume
4
Number
178
Pages
2382-2386
Language
french
Abstract
The restless legs syndrome (RLS) is a frequent, often unrecognized disorder in the elderly. The diagnosis is essentially based on the clinical history. The RLS is characterized by (1) an urge to move the limbs, usually associated with abnormal sensations in the legs; (2) symptoms are worse at rest; (3) they are relieved by movements; (4) they mainly occur in the evening or at night. Specific diagnostic criteria have been developed for cognitively impaired elderly persons. The RLS is a chronic disorder with high impact on sleep and quality of life. Treatment is symptomatic and recommended drugs are dopaminergic agents, opioids, and gabapentine.
Keywords
Aged, 80 and over, Alzheimer Disease/complications, Amines/therapeutic use, Anticonvulsants/therapeutic use, Benzodiazepines/therapeutic use, Cyclohexanecarboxylic Acids/therapeutic use, Diagnosis, Differential, Dopamine Agents/therapeutic use, Female, Humans, Narcotics/therapeutic use, Quality of Life, Restless Legs Syndrome/complications, Restless Legs Syndrome/diagnosis, Sleep Disorders/etiology, Tranquilizing Agents/therapeutic use, gamma-Aminobutyric Acid/therapeutic use
Pubmed
Create date
04/09/2011 15:04
Last modification date
15/10/2024 6:26